Academic Journal
Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting.
| Τίτλος: | Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting. |
|---|---|
| Συγγραφείς: | Kersting, David1 (AUTHOR), Kim, Moon-Sung2 (AUTHOR), Puellen, Lukas3 (AUTHOR), Seidl-Rathkopf, Kathi4 (AUTHOR), Schinwald, Nicole4 (AUTHOR), Mpofu, Philani5 (AUTHOR), Altomare, Ivy5 (AUTHOR), Sujenthiran, Arun6 (AUTHOR), Royce, Trevor Joseph5 (AUTHOR), Buhl, Christoph4 (AUTHOR), Grünwald, Viktor7 (AUTHOR), Herrmann, Ken1 (AUTHOR), Kleesiek, Jens2 (AUTHOR), Hadaschik, Boris A.3 (AUTHOR) |
| Πηγή: | Journal of Clinical Oncology. 2024 Supplement 4, Vol. 42, p143-143. 235p. |
| Βάση Δεδομένων: | Supplemental Index |
καταχωρήστε σχόλιο πρώτοι!